New Treatment of Advanced Melanoma from the Viewpoint of Patient and Hospital Management

DOI Web Site
  • Yamasaki Osamu
    Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Melanoma Center, Okayama University Hospital
  • Kaji Tatsuya
    Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Melanoma Center, Okayama University Hospital
  • Umemura Hiroshi
    Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Melanoma Center, Okayama University Hospital
  • Hirai Yoji
    Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
  • Morizane Shin
    Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
  • Hamada Toshihisa
    Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
  • Takata Minoru
    Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
  • Iwatsuki Keiji
    Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Melanoma Center, Okayama University Hospital
  • Katsui Kuniaki
    Melanoma Center, Okayama University Hospital Department of Proton Beam Therapy, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
  • Gouchi Akira
    Division of Medical Informatics, Okayama University Hospital

Bibliographic Information

Other Title
  • 病院現況および患者視点からみた進行期悪性黒色腫に対する新規治療
  • ビョウイン ゲンキョウ オヨビ カンジャ シテン カラ ミタ シンコウキ アクセイ コクショク シュ ニ タイスル シンキ チリョウ

Search this article

Abstract

<p>Background: The costs of new treatments for patients with advanced melanoma are high, and national medical expenses may increase.</p><p>Methods: We conducted a questionnaire survey about medical expenses for patients with stage II-IV melanoma and compared it by treatment. We compared the medical results in our department in the first half of 2015 with those of the previous year. We also investigated the clinical response, convalescence, and costs of the new treatment in an advanced melanoma patient treated during the period of from September, 2014 to March, 2016.</p><p>Results: In the new treatment group medical expenses became higher than 20% of the cost of living, and a feeling of burden was strong. Medical treatment fees, medical treatment unit price, and medical expenses rates increased in comparison with the previous year. The treatments and duration of treatments in 24 patients undergoing the new treatment varied, but the drug costs were always very high.</p><p>Conclusions: Dermatologists should understand the medical burdens on patient with advanced melanoma, and the hospital management, as well as the problem of national medical expenses; they should be also aware of the economic issues of new treatments for advanced melanoma.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top